Health Care & Life Sciences » Pharmaceuticals | Pain Therapeutics Inc.

Pain Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
49,838.00
40,590.00
31,299.00
18,714.00
10,479.00
Other Current Assets
265.00
239.00
392.00
356.00
184.00
Total Current Assets
50,103.00
40,829.00
31,691.00
19,070.00
10,663.00
Net Property, Plant & Equipment
-
65.00
215.00
232.00
156.00
Other Assets
-
12.00
12.00
-
12.00
Total Assets
50,103.00
40,906.00
31,918.00
19,302.00
10,831.00
Accounts Payable
445.00
173.00
-
-
424.00
Other Current Liabilities
1,356.00
677.00
2,551.00
665.00
708.00
Total Current Liabilities
1,801.00
850.00
2,551.00
665.00
1,132.00
Total Liabilities
1,801.00
850.00
2,551.00
665.00
1,132.00
Common Equity (Total)
48,302.00
40,056.00
29,367.00
18,637.00
9,699.00
Total Shareholders' Equity
48,302.00
40,056.00
29,367.00
18,637.00
9,699.00
Total Equity
48,302.00
40,056.00
29,367.00
18,637.00
9,699.00
Liabilities & Shareholders' Equity
50,103.00
40,906.00
31,918.00
19,302.00
10,831.00

About Pain Therapeutics

View Profile
Address
7801 North Capital of Texas Highway
Austin Texas 78731
United States
Employees -
Website http://www.paintrials.com
Updated 09/14/2018
Pain Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of novel drugs. Its drug candidate includes REMOXY, which is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. The company was founded by Remi Barbier and Barry M.